Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae

BACKGROUND: The efficacy of ceftazidime-avibactam—a cephalosporin–β-lactamase inhibitor combination with in vitro activity against Klebsiella pneumoniae carbapenemase–producing carbapenem-resistant Enterobacteriaceae (CRE)—compared with colistin remains unknown. METHODS: Patients initially treated w...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Infect Dis
Autors principals: van Duin, David, Lok, Judith J, Earley, Michelle, Cober, Eric, Richter, Sandra S, Perez, Federico, Salata, Robert A, Kalayjian, Robert C, Watkins, Richard R, Doi, Yohei, Kaye, Keith S, Fowler, Vance G, Paterson, David L, Bonomo, Robert A, Evans, Scott
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2018
Matèries:
Articles and Commentaries
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5850032/
https://ncbi.nlm.nih.gov/pubmed/29020404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cix783
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars